Integrative Analysis of DNA Methylation and microRNA Expression Reveals Mechanisms of Racial Heterogeneity in Hepatocellular Carcinoma

Rency S Varghese; Megan E Barefoot; Sidharth Jain; Yifan Chen; Yunxi Zhang; Amber Alley; Alexander H Kroemer; Mahlet G Tadesse; Deepak Kumar; Zaki A Sherif; Habtom W Ressom

doi:10.3389/fgene.2021.708326

Integrative Analysis of DNA Methylation and microRNA Expression Reveals Mechanisms of Racial Heterogeneity in Hepatocellular Carcinoma

Front Genet. 2021 Sep 7:12:708326. doi: 10.3389/fgene.2021.708326. eCollection 2021.

Authors

Affiliations

¹ Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States.
² MedStar Georgetown University Hospital, Washington, DC, United States.
³ Department of Mathematics and Statistics, Georgetown University, Washington, DC, United States.
⁴ Department of Pharmaceutical Sciences, North Carolina Central University, Durham, NC, United States.
⁵ Department of Biochemistry and Molecular Biology, College of Medicine, Howard University, Washington, DC, United States.

Abstract

Pathologic alterations in epigenetic regulation have long been considered a hallmark of many cancers, including hepatocellular carcinoma (HCC). In a healthy individual, the relationship between DNA methylation and microRNA (miRNA) expression maintains a fine balance; however, disruptions in this harmony can aid in the genesis of cancer or the propagation of existing cancers. The balance between DNA methylation and microRNA expression and its potential disturbance in HCC can vary by race. There is emerging evidence linking epigenetic events including DNA methylation and miRNA expression to cancer disparities. In this paper, we evaluate the epigenetic mechanisms of racial heterogenity in HCC through an integrated analysis of DNA methylation, miRNA, and combined regulation of gene expression. Specifically, we generated DNA methylation, mRNA-seq, and miRNA-seq data through the analysis of tumor and adjacent non-tumor liver tissues from African Americans (AA) and European Americans (EA) with HCC. Using mixed ANOVA, we identified cytosine-phosphate-guanine (CpG) sites, mRNAs, and miRNAs that are significantly altered in HCC vs. adjacent non-tumor tissue in a race-specific manner. We observed that the methylome was drastically changed in EA with a significantly larger number of differentially methylated and differentially expressed genes than in AA. On the other hand, the miRNA expression was altered to a larger extent in AA than in EA. Pathway analysis functionally linked epigenetic regulation in EA to processes involved in immune cell maturation, inflammation, and vascular remodeling. In contrast, cellular proliferation, metabolism, and growth pathways are found to predominate in AA as a result of this epigenetic analysis. Furthermore, through integrative analysis, we identified significantly differentially expressed genes in HCC with disparate epigenetic regulation, associated with changes in miRNA expression for AA and DNA methylation for EA.

Keywords: DNA methylation; cancer disparities; epigenomic and transcriptomic data; hepatocellular carcinoma; miRNA expression.

Abstract

Grants and funding